Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 November 2025 | Story Precious Shamase | Photo Blackhood Photography
Community Development Conference
Attendees at the Community Development Conference 2025.

The University of the Free State (UFS) proudly hosted South Africa's inaugural Community Development Conference, a landmark national event. Held at the scenic Golden Gate Hotel and Chalets, the conference drew an overwhelming oversubscription of 205 delegates, bringing together a diverse community of practitioners, academics, government representatives, and civil society under the theme: "Grounding the future: Community voices and practice pathways for inclusive development." 

In his opening and welcome address, Prof Mogomme Masoga, Dean of the Faculty of the Humanities, expressed deep gratitude for the extensive support received. "Thank you to the government departments represented here - Social Development, CoGTA, Health, and others - as well as to the many non-profit organisations that have lent their unwavering support," he said, emphasising the importance of inter-sectoral collaboration. 

 

National and international collaboration 

The UFS worked in strategic partnership with the University of Johannesburg (UJ), the University of KwaZulu-Natal (UKZN), and the University of the Western Cape (UWC) to bring this significant platform to life. This collaboration reinforced the message that community development is "everyone’s business", a sentiment reflected in the broad and diverse participation. 

International representation included delegates from Botswana, Zimbabwe, Austria, Nigeria, Lesotho, and Eswatini, alongside participants linked to institutions in Germany and North America. Nationally, delegates travelled from across South Africa – including the Western Cape, North-West, Northern Cape, Gauteng, and KwaZulu-Natal - demonstrating the conference's wide-reaching relevance and appeal. 

 

Keynote address: Managing the developmental state 

A major highlight of the second day was the keynote address delivered by Onkematse Kabasia, Head of the Department of Social Development in KwaZulu-Natal. His presentation, titled "South Africa's path to a developmental state: A managerial analysis of the Department of Social Development's transition," offered a compelling exploration of the shifts required within government departments to effectively manage and advance the objectives of a developmental state. 

Kabasia outlined the managerial challenges and institutional reforms necessary to transition from a predominantly welfare-oriented system to one that actively drives inclusive social and economic development. His insights sparked robust discussion among academics, practitioners, and government delegates, highlighting the crucial role of efficient public-sector management in strengthening the community development sector ahead of the 2026 National Community Development Conference. 

 

Charting the path to 2026 

More than a standalone event, the inaugural conference forms part of a strategic lead-up to the 2026 National Community Development Conference. Its core purpose was to elevate community voices, promote ethical practice, and build collaborative pathways toward a professionalised, effective community development sector in South Africa.

The programme offered a rich and balanced mix of academic papers, interactive panel discussions, and practical workshops, ensuring a comprehensive exploration of the conference theme. 

A notable highlight from the first day included an address by Norman (Pankie) Matomela on "CoGTA and Community Work," followed by an insightful national perspective on community development presented by Peter Netshipale. These contributions laid a strong foundation for the discussions that followed. 

 

Advancing action research and policy implementation  

A key takeaway from the conference was the strong collective commitment to Action Research and the translation of policy into effective practice. Delegates expressed a shared resolve to move beyond theoretical discussion toward tangible, results-oriented community development. 

Participants agreed that effective community development requires: 

Action research: The use of participatory methodologies that engage communities directly and deliver practical, context-specific solutions. 

Policy implementation: The successful operationalisation of high-level policies - such as those discussed by keynote speakers Kabasia and Matomela - into on-the-ground interventions that drive inclusive development. 

This emphasis on results and accountability underscores the conference's role as a crucial step toward a more professionalised and impactful community development sector in South Africa.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept